EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Transfer RNA and small molecule therapeutics for aminoacyl‐ tRNA synthetase diseases

Tristan N Samuels, Fanqi Wu, Maria Mahmood, Wajd A Abuzaid, Nancy Sun, Angelica Moresco, Victoria M Siu, Patrick O'Donoghue iD, Ilka U Heinemann iD

The FEBS Journal · 2025

DOI: 10.1111/febs.17361 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FEBS Journal, 2025. Verfasst von Tristan N Samuels und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Canada. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, RNA, Transfer, Small Molecule Libraries. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Ontario Ministry of Research and Innovation, Rare Diseases: Models and Mechanism Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aminoacyl‐tRNA synthetases catalyze the ligation of a specific amino acid to its cognate tRNA. The resulting aminoacyl‐tRNAs are indispensable intermediates in protein biosynthesis, facilitating the precise decoding of the genetic code. Pathogenic alleles in the aminoacyl‐tRNA synthetases can lead to several dominant and recessive disorders. To date, disease‐specific treatments for these conditions are largely unavailable. We review pathogenic human synthetase alleles, the molecular and cellular mechanisms of tRNA synthetase diseases, and emerging approaches to allele‐specific treatments, including small molecules and nucleic acid‐based therapeutics. Current treatment approaches to rescue defective or dysfunctional tRNA synthetase mutants include supplementation with cognate amino acids and delivery of cognate tRNAs to alleviate bottlenecks in translation. Complementary approaches use inhibitors to target the integrated stress response, which can be dysregulated in tRNA synthetase diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesRNA, TransferSmall Molecule LibrariesHumansProtein BiosynthesisMutationAnimals

Stichwörter der Autor:innen

GCN2aminoacyl‐tRNA synthetasegenetic disorderstRNA therapeutics

Substanzen

Amino Acyl-tRNA SynthetasesRNA, TransferSmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, Canada.
  • Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, Canada.
  • Children's Health Research Institute, London, Canada.
  • Department of Chemistry, Western University, London, Canada.

ORCID-Profile: Patrick O'Donoghue, Ilka U Heinemann

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Ontario Ministry of Research and Innovation
  • Rare Diseases: Models and Mechanism Network
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Samuels, T. N., Wu, F., Mahmood, M., Abuzaid, W. A., Sun, N., Moresco, A., Siu, V. M., O'Donoghue, P., & Heinemann, I. U. (2025). Transfer RNA and small molecule therapeutics for aminoacyl‐ tRNA synthetase diseases. The FEBS Journal. https://doi.org/10.1111/febs.17361

Vancouver

Samuels TN, Wu F, Mahmood M, Abuzaid WA, Sun N, Moresco A, et al. Transfer RNA and small molecule therapeutics for aminoacyl‐ tRNA synthetase diseases. The FEBS Journal. 2025. doi:10.1111/febs.17361

BibTeX
@article{Samuels2025,
  author = {Samuels, Tristan N and Wu, Fanqi and Mahmood, Maria and Abuzaid, Wajd A and Sun, Nancy and Moresco, Angelica and Siu, Victoria M and O'Donoghue, Patrick and Heinemann, Ilka U},
  title = {Transfer RNA and small molecule therapeutics for aminoacyl‐ tRNA synthetase diseases},
  journal = {The FEBS Journal},
  year = {2025},
  doi = {10.1111/febs.17361}
}
Kostenlos starten →